marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q1
added 05-06-2024
ShockWave Medical Balance Sheet 2011-2024 | SWAV
Annual Balance Sheet ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
407 M | -131 M | -77.5 M | -43.5 M | -125 M | -24.6 M | -51.9 M | - | - | - | - | - | - |
Long Term Debt |
732 M | 24.2 M | 11.6 M | 7.49 M | 7.15 M | 13.4 M | - | - | - | - | - | - | - |
Long Term Debt Current |
3.64 M | 1.28 M | 1.74 M | 873 K | 774 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 15.3 M | 13.5 M | 138 M | - | - | - | - | - | - |
Total Current Liabilities |
104 M | 63.4 M | 51.6 M | 25.6 M | 24 M | - | - | - | - | - | - | - | - |
Total Liabilities |
898 M | 135 M | 104 M | 46.4 M | 39.3 M | 22.9 M | 143 M | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
110 M | -36.8 M | -253 M | - | -178 M | -127 M | -85.8 M | - | - | - | - | - | - |
Total Assets |
1.57 B | 646 M | 346 M | 272 M | 232 M | 53.4 M | 59.3 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
328 M | 157 M | 90.9 M | 51.9 M | 139 M | - | - | - | - | - | - | - | - |
Book Value |
669 M | 511 M | 242 M | 226 M | 193 M | 30.5 M | -83.3 M | - | - | - | - | - | - |
Total Shareholders Equity |
669 M | 511 M | 242 M | 226 M | 193 M | -123 M | -83.3 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet ShockWave Medical
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
733 M | 731 M | 24.3 M | 24.2 M | 24.2 M | 14.9 M | 6.44 M | 9.03 M | 11.6 M | 14.2 M | 12.8 M | 7.21 M | 13.3 M | 13.3 M | 13.3 M | 16.1 M | 7.15 M | 7.15 M | 7.15 M | 7.15 M | 13.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
892 M | 873 M | 170 M | 213 M | 135 M | 120 M | 112 M | 105 M | 104 M | 78.7 M | 68 M | 64.8 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 39.3 M | 39.3 M | 39.3 M | 39.3 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
166 M | 66.2 M | 31.2 M | 2.31 M | -36.8 M | -178 M | -213 M | -238 M | -253 M | -266 M | -268 M | -267 M | -244 M | -244 M | -244 M | -244 M | -178 M | -178 M | -178 M | -178 M | -127 M | -127 M | -127 M | -127 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.64 B | 1.47 B | 787 M | 783 M | 646 M | 476 M | 417 M | 373 M | 346 M | 299 M | 276 M | 269 M | 272 M | 272 M | 272 M | 272 M | 232 M | 232 M | 232 M | 232 M | 53.4 M | 53.4 M | 53.4 M | 53.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
282 M | 498 M | 141 M | 281 M | 157 M | 128 M | 99.9 M | 66.3 M | 89.2 M | 92.6 M | 85.7 M | 57 M | 51.9 M | 50.4 M | 50.4 M | 50.4 M | 139 M | 139 M | 139 M | 139 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 51.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
752 M | 601 M | 617 M | 571 M | 511 M | 356 M | 305 M | 268 M | 242 M | 220 M | 208 M | 204 M | 226 M | 226 M | 226 M | 226 M | 193 M | 193 M | 193 M | 193 M | 30.2 M | 30.2 M | 30.2 M | 30.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
752 M | 601 M | 617 M | 571 M | 511 M | 356 M | 305 M | 268 M | 242 M | 220 M | 208 M | 204 M | 226 M | 226 M | 226 M | 226 M | 193 M | 193 M | 193 M | 193 M | -123 M | -123 M | -123 M | -123 M | -83.3 M | - | - | - | -53.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency